stella
beta
Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation — Stella
Recruiting
Back to Hepatocellular Carcinoma trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Trial locations
(1 site)
China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, Wuhan
View full record on ClinicalTrials.gov